Why Fitbit is Medtech's Next Biggest Thing

This week, Fitbit is on Omar Ford 's mind. MD+DI's managing editor breaks down why he believes the company has the potential to become a medtech powerhouse.

Omar Ford

June 11, 2020

Earlier this month, Fitbit made a move that was a pretty big deal. The company announced it had received Emergency Use Authorization for or a low-cost emergency ventilator to help address patients’ needs during the COVID-19 pandemic. The EUA follows a pattern of significant moves the San Francisco, CA-based company has made over the past few years.

From big collaborations to conducting studies, to receiving nods from FDA, the wearables company is positioning itself to be highly effective in the medtech industry. 

As it stands now Fitbit is set to be acquired by Google. But that hasn't stopped the company from expanding its presence in medtech. 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like